Cyprus assures that EU e-prescriptions will not cause drug shortages
The National e-Health Authority of the Republic of Cyprus has stated that the implementation of the MyHealth@EU cross-border electronic prescription system poses no threat to the availability of medicines on the island.
The statement was made following concerns previously expressed by the Pharmaceutical Association of Cyprus regarding the system's potential impact on the country's pharmaceutical market.
The authority emphasized that the mechanism for cross-border dispensing of medicines is not a new practice. It operates under EU Directive 2011/24/EU, which allows citizens of EU countries to receive medical care and purchase medicines in other member states.
It is noted that the main difference of the current system lies in the use of the modern digital platform MyHealth@EU, which ensures the secure exchange of medical information between EU countries.
The department explained that the new system allows doctors and pharmacists to see prescriptions already issued and dispensed to a patient in their country of residence. This helps reduce duplicate prescriptions and promotes more rational use of medicines.
The National Authority also stressed that the responsibility for prescribing drugs remains with the treating physician.
Author
Born in the city of shipbuilders, Mykolaiv (Ukraine). Currently living in Moscow. Diplomat in reserve. More than 10 years of experience in the Mediterranean region (Greece, Cyprus). Until 2015, First Secretary of the Russian Embassy in Cyprus. Fluent in Greek and English. Completed civil service in…
You may also be interested in:
- Child abduction in Limassol reveals serious gaps in Cyprus's security system
- Prices in Cyprus stores continue to rise, while diesel in Paphos remains the most expensive
- Construction materials continue to become more expensive in Cyprus
- Tourism in Cyprus: April decline slows down, but figures remain negative
- Halloumi producers demand reversal of goat and sheep milk ratio reduction
